DexCom (DXCM) Tops Q4 EPS by 37c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Dexcom Reports Fourth Quarter and Fiscal Year 2018 Financial Results
February 21, 2019 4:10 PM ESTThe Company also Announces Expansion and Reorganization of its Customer Support Functions
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December31, 2018.
Fourth Quarter 2018 Highlights:
Revenue grew 53% versus the same quarter of the prior year to $338.0 million U.S. revenue growth of 50% and international revenue growth of 72% Advanced next generation pipeline and improved future profitability profile with amended Verily collaboration Strengthened balance sheet to provide increased financial and... More


